Gold prices steady ahead of Fed decision; weekly weakness noted
Investing.com - Tenet Healthcare (NYSE: THC) reported second quarter EPS of $4.02, $1.14 better than the analyst estimate of $2.88. Revenue for the quarter came in at $5.27B versus the consensus estimate of $5.16B.
Guidance
Tenet Healthcare sees FY 2025 EPS of $15.55-$16.21 versus the analyst consensus of $12.83.
Tenet Healthcare sees FY 2025 revenue of $20.95M-$21.25M versus the analyst consensus of $20.92M.
Tenet Healthcare’s stock price closed at $174.65. It is up 40.57% in the last 3 months and up 25.94% in the last 12 months.
Tenet Healthcare saw 15 positive EPS revisions and 2 negative EPS revisions in the last 90 days. See Tenet Healthcare’s stock price’s past reactions to earnings here.
According to InvestingPro, Tenet Healthcare’s Financial Health score is "great performance".
Check out Tenet Healthcare’s recent earnings performance, and Tenet Healthcare’s financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar